Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Yoshimura, Takeru ^a   Sonoda, Koh Hei ^a   Sugahara, Mika ^a   Mochizuki, Yasutaka ^a   Enaida, Hiroshi ^a   Oshima, Yuji ^a   Ueno, Akifumi ^a   Hata, Yasuaki ^a   Yoshida, Hiroki ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EOTAXIN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AUTACOID; CYTOKINE; VASCULOTROPIN A;

AQUEOUS HUMOR; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RETINA DETACHMENT; RETINA VEIN OCCLUSION; VITREORETINOPATHY; VITREOUS BODY; AGED; BIOLOGICAL MODEL; BLOOD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; RETINA DISEASE; SOLUBILITY;

AGED; CYTOKINES; DIABETIC RETINOPATHY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RETINAL DISEASES; RETINAL VEIN OCCLUSION; SOLUBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 77949537099     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008158     Document Type: Article

References (51)

1. Canton A, Martinez-Caceres EM, Hernandez C, Espejo C, Garcia-Arumi J, et al. (2004) CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis. Arch Ophthalmol 122: 743-749.
2. Charteris DG, Hiscott P, Grierson I, Lightman SL (1992) Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Ophthalmology 99: 1364-1367.
3. Oppenheim JJ (2001) Cytokines: past, present, and future. Int J Hematol 74: 3-8.
4. Vilcek J, Feldmann M (2004) Historical review: Cytokines as therapeutics and targets of therapeutics. Trends Pharmacol Sci 25: 201-209.
5. Struyf S, Proost P, Van Damme J (2003) Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 81: 1-44.
6. Strieter RM, Gomperts BN, Keane MP (2007) The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 117: 549-556.
7. Keeley EC, Mehrad B, Strieter RM (2008) Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol 28: 1928-1936.
8. Rehak J, Rehak M (2008) Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33: 111-131.
9. Lewandowska-Furmanik M, Pozarowska D, Pozarowski P, Matysik A (2002) TH1/TH2 balance in the subretinal fluid of patients with rhegmatogenous retinal detachment. Med Sci Monit 8: CR526-528.
10. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487.
11. Abu el Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT (1992) Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 114: 731-736.
12. de Boer JH, Hack CE, Verhoeven AJ, Baarsma GS, de Jong PT, et al. (1993) Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci 34: 3376-3385.
13. Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, et al. (1995) Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 14: 1045-1053.
14. Capeans C, De Rojas MV, Lojo S, Salorio MS (1998) C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Retina 18: 546-550.
15. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, et al. (1998) Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 105: 412-416.
16. Yuuki T, Kanda T, Kimura Y, Kotajima N, Tamura J, et al. (2001) Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications 15: 257-259.
17. Vignali DA (2000) Multiplexed particle-based flow cytometric assays. J Immunol Methods 243: 243-255.
18. Banerjee S, Savant V, Scott RA, Curnow SJ, Wallace GR, et al. (2007) Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci 48: 2203-2207.
19. Maier R, Weger M, Haller-Schober EM, El-Shabrawi Y, Wedrich A, et al. (2008) Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Mol Vis 14: 637-643.
20. Djoba Siawaya JF, Roberts T, Babb C, Black G, Golakai HJ, et al. (2008) An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS ONE 3: e2535.
21. Yoshimura T, Sonoda KH, Ohguro N, Ohsugi Y, Ishibashi T, et al. (2009) Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford) 48: 347-354.
22. Takase H, Futagami Y, Yoshida T, Kamoi K, Sugita S, et al. (2006) Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci 47: 1557-1561.
23. Chan CC, Buggage RR, Nussenblatt RB (2002) Intraocular lymphoma. Curr Opin Ophthalmol 13: 411-418.
24. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, et al. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. Faseb J 18: 1450-1452.
25. Kastelan S, Zjacic-Rotkvic V, Kastelan Z (2007) Could diabetic retinopathy be an autoimmune disease? Med Hypotheses 68: 1016-1018.
26. Adamis AP, Berman AJ (2008) Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30: 65-84.
27. Park SP, Ahn JK (2008) Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion. Clin Experiment Ophthalmol 36: 831-835.
28. Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, et al. (2009) Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy. Ophthalmology 116: 921-926.
29. Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, CervantesCastaneda RA, et al. (2009) Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology 116: 902-911; quiz 912-903.
30. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271: 736-741.
31. Maruo N, Morita I, Shirao M, Murota S (1992) IL-6 increases endothelial permeability in vitro. Endocrinology 131: 710-714.
32. Yoshida A, Yoshida S, Khalil AK, Ishibashi T, Inomata H (1998) Role of NFkappaB- mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol Vis Sci 39: 1097-1106.
33. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA (1994) Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 91: 3652-3656.
34. Xu LL, Warren MK, Rose WL, Gong W, Wang JM (1996) Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol 60: 365-371.
35. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, et al. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 90: 10193-10197.
36. Stein B, Baldwin AS Jr (1993) Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NFkappa B. Mol Cell Biol 13: 7191-7198.
37. Roebuck KA, Carpenter LR, Lakshminarayanan V, Page SM, Moy JN, et al. (1999) Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol 65: 291-298.
38. Goebeler M, Gillitzer R, Kilian K, Utzel K, Brocker EB, et al. (2001) Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood 97: 46-55.
39. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
40. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62.
41. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
42. Pages G, Pouyssegur J (2005) Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors. Cardiovasc Res 65: 564-573.
43. Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, et al. (2006) Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 142: 961-969.
44. Funatsu H, Noma H, Mimura T, Eguchi S, Hori S (2009) Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116: 73-79.
45. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA (1995) Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113: 1538-1544.
46. Lutty GA, McLeod DS, Merges C, Diggs A, Plouet J (1996) Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 114: 971-977.
47. Charteris DG (1995) Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 79: 953-960.
48. Abu el-Asrar AM, Van Damme J, Put W, Veckeneer M, Dralands L, et al. (1997) Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders. Am J Ophthalmol 123: 599-606.
49. Mitamura Y, Takeuchi S, Yamamoto S, Yamamoto T, Tsukahara I, et al. (2002) Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy. Jpn J Ophthalmol 46: 218-221.
50. Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, et al. (2007) Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A 104: 2425-2430.
51. Chong DY, Boehlke CS, Zheng QD, Zhang L, Han Y, et al. (2008) Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 49: 3193-3200.